E-ISSN 2218-6050 | ISSN 2226-4485
 

Case Report


Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism

Pauline Le Corre, Mathieu R. Faucher.


Abstract
Background:
Hyposomatotropism is an extremely rare disease in cats. It is associated with a stunted growth and suspected severely decreased life expectancy based on the very few cases that have been reported so far in this species. To date, no treatment has been recommended in cats.

Case Description:
A 4-month-old female British Shorthair was presented for a stunted growth without any other clinical signs reported. All other causes of growth retardation were excluded and persistently low circulating IGF-1 levels were documented, allowing to diagnose this kitten with presumed isolated GH-deficiency. This cat was treated with recombinant human GH subcutaneously for 20 weeks. At the time of treatment discontinuation, the cat had reached the weight of his littermates. No adverse effects to the treatment was observed. The serum IGF-1 level was measured 6 months after treatment discontinuation and was within the reference range.

Conclusion:
This case report describes the successful treatment of a highly presumed GH-deficient cat with recombinant human GH without adverse effect. Recombinant human GH might be a reasonable treatment option in GH-deficient cats considering the grave prognosis associated with this disease in the few cases described.

Key words: Endocrine disease; GH; IGF-1; Pituitary dwarf; Stunted growth.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pauline Le Corre
Articles by Mathieu R. Faucher
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Corre PL, Faucher MR. Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism. Open Vet. J.. 2025; 15(10): 5408-5414. doi:10.5455/OVJ.2025.v15.i10.59


Web Style

Corre PL, Faucher MR. Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism. https://www.openveterinaryjournal.com/?mno=259565 [Access: November 10, 2025]. doi:10.5455/OVJ.2025.v15.i10.59


AMA (American Medical Association) Style

Corre PL, Faucher MR. Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism. Open Vet. J.. 2025; 15(10): 5408-5414. doi:10.5455/OVJ.2025.v15.i10.59



Vancouver/ICMJE Style

Corre PL, Faucher MR. Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism. Open Vet. J.. (2025), [cited November 10, 2025]; 15(10): 5408-5414. doi:10.5455/OVJ.2025.v15.i10.59



Harvard Style

Corre, P. L. & Faucher, . M. R. (2025) Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism. Open Vet. J., 15 (10), 5408-5414. doi:10.5455/OVJ.2025.v15.i10.59



Turabian Style

Corre, Pauline Le, and Mathieu R. Faucher. 2025. Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism. Open Veterinary Journal, 15 (10), 5408-5414. doi:10.5455/OVJ.2025.v15.i10.59



Chicago Style

Corre, Pauline Le, and Mathieu R. Faucher. "Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism." Open Veterinary Journal 15 (2025), 5408-5414. doi:10.5455/OVJ.2025.v15.i10.59



MLA (The Modern Language Association) Style

Corre, Pauline Le, and Mathieu R. Faucher. "Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism." Open Veterinary Journal 15.10 (2025), 5408-5414. Print. doi:10.5455/OVJ.2025.v15.i10.59



APA (American Psychological Association) Style

Corre, P. L. & Faucher, . M. R. (2025) Successful treatment with recombinant human GH in a kitten with suspected congenital hyposomatotropism. Open Veterinary Journal, 15 (10), 5408-5414. doi:10.5455/OVJ.2025.v15.i10.59